Specific reductions of striatal prodynorphin and D1 dopamine receptor messenger RNAs during cocaine abstinence

Molecular Brain Research

Volumn 56, Issue 1-2, 1998, Pages 162-168

  Svensson, Pernilla ^a   Hurd, Yasmin L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cocaine withdrawal; D2 dopamine receptor; Proenkephalin; Rat; Striatum

Indexed keywords

COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA; OPIATE PEPTIDE; PRODYNORPHIN; PROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG WITHDRAWAL; GENE EXPRESSION; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; CORPUS STRIATUM; ENKEPHALINS; MALE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0032078416     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00041-2     Document Type: Article

References (41)

1. Bozarth M. New perspectives on cocaine addiction: recent findings from animal research. Can. J. Physiol. Pharmacol. 67:1989;1158-1167.
2. Branch A.D., Unterwald E.M., Lee S.E., Kreek M.J. Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Mol. Brain Res. 14:1992;231-238.
3. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-270.
4. 1-receptors in the nucleus accumbens. Psychopharmacology. 115:1994;110-114.
5. Civelli O., Douglas J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. U.S.A. 82:1985;4291-4295.
6. Cuello A.C., Paxinos G. Evidence for a long leu-enkephalin striatopallidal pathway in the rat brain. Nature. 271:1978;178-180.
7. Daunais J.B., McGinty J.F. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse. 18:1994;35-45.
8. Daunais J.B., Roberts D.C.S., McGinty J.F. Cocaine self-administration increases prodynorphin, but not c-fos, mRNA in rat striatum. NeuroReport. 4:1993;543-546.
9. Del Fiacco M., Cuello A.C. Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus. Brain Res. 231:1982;1-17.
10. Gawin F.H., Kleber H.D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch. Gen. Psychiatry. 43:1989;107-113.
11. 2 dopamine receptor regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
12. 1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proc. Natl. Acad. Sci. U.S.A. 89:1992;11988-11992.
13. Y.L. Hurd, Cocaine effects on dopamine and opioid peptide neural system: implications for human cocaine abuse, in: M.D. Majewska (Ed.), National Institute on Drug Abuse Research Monograph, Neurotoxicity and Neuropathology Associated with Cocaine/Stimulants Abuse, Supt. of Docs., U.S. Govt. Print. Off., Washington, DC, 1996, pp. 94-116.
14. Hurd Y.L., Brown E., Finlay J., Fibiger H.C., Gerfen C. Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol. Brain Res. 13:1992;165-170.
15. Hurd Y.L., Herkenham M. Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Mol. Brain Res. 16:1992;97-104.
16. 1 dopamine receptor involvement, Eur. J. Neurosci., 1997, in press.
17. Kalivas P.W., Duffy P., DuMars L.A., Skinner C. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J. Pharmacol. Exp. Ther. 245:1988;485-492.
18. 2-receptor function. J. Pharmacol. Exp. Ther. 269:1994;743-749.
19. Laurier L.G., Corrigall W.A., George S.R. Dopamine receptor density, sensitivity and mRNA levels are altered following self-administration of cocaine in the rat. Brain Res. 634:1994;31-40.
20. 1 dopamine receptor gene. Proc. Natl. Acad. Sci. U.S.A. 88:1991;4205-4209.
21. Le Moine C., Normand E., Guitteny A.F., Fouque B., Teoule R., Bloch B. Dopamine receptor gene expression by enkephalin neurons in rat forebrain. Proc. Natl. Acad. Sci. U.S.A. 87:1990;230-234.
22. McGregor A., Roberts D.C.S. Dopaminergic antagonism within the nucleus accumbens or the amygdala produces differential effects on intravenous cocaine self-administration under fixed and progressive ratio schedules of reinforcement. Brain Res. 624:1993;245-252.
23. 1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6723-6727.
24. 2 dopamine receptors produced by alternative RNA splicing. Nature. 342:1989;926-929.
25. Parent A., Hazrati L.-N. Functional anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20:1995;91-127.
26. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1982.
27. Post R.M., Lockfeld A., Squillace K.M., Contel N.R. Drug-environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci. 28:1981;755-760.
28. 2 dopamine receptor mRNA expression after chronic cocaine in the nucleus accumbens and striatum of the rat. Eur. Neuropsychopharmacol. 5:1995;465-469.
29. Robinson T.E., Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharmacol. 85:1982;253-254.
30. 2-like dopamine receptor agonists. Science. 271:1996;1586-1589.
31. 2, receptors. Psychopharmacology. 123:1996;303-306.
32. Sivam S.P. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J. Pharmacol. Exp. Ther. 250:1989;818-824.
33. Spangler R., Ho A., Zhou Y., Maggos C.E., Yuferov V., Kreek M.J. Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA. Mol. Brain Res. 38:1996;71-76.
34. Spangler R., Unterwald E.M., Kreek M.J. 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Mol. Brain Res. 19:1993;323-327.
35. Spangler R., Zhou Y., Maggos C.E., Zlobin A., Ho A., Kreek M.J. Dopamine antagonist and 'binge' cocaine effects on rat opioid and dopamine transporter mRNAs. NeuroReport. 7:1996;2196-2200.
36. 2-receptor mRNA expression in the olfactory tubercle by cocaine. Mol. Brain Res. 19:1993;313-317.
37. Steiner H., Gerfen C. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in the striatum. J. Neurosci. 13:1993;5066-5081.
38. 1-like receptor stimulation. J. Pharmacol. Exp. Ther. 278:1996;347-353.
39. Vincent S., Hökfelt T., Christensson I., Terenius L. Immunohistochemical evidence for a dynorphin immunoreactive striatonigral pathway. Eur. J. Pharmacol. 85:1982;251-252.
40. 1-receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
41. Yoshikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. J. Biol. Chem. 259:1984;14301-14308.